Harry Welten

Europe, Switzerland

Description

Harry has 20 years of international executive experience, more than 11 of which as a CFO in the biotech industry. Prior to joining Cytos, Mr...

Investor Profile

Harry Welten has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

Series A (100%)

Country Focus

Switzerland (100%)

Industry Focus

Biotechnology
Clinical Trials
Therapeutics
Health Care
Medical

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Harry Welten frequently co-invest with?

Novartis Venture Fund

Europe, Basel-Stadt, Switzerland, Basel

Co-Investments: 1

Versant Ventures

North America, California, United States, Menlo Park

Co-Investments: 1

Novo Ventures

Europe, Hovedstaden, Denmark, Bagsværd

Co-Investments: 1

Which angels does Harry Welten often collaborate with?

André J. Mueller

Shared Deals: 1

What are some of recent deals done by Harry Welten?

Virometix

Schlieren, Zurich, Switzerland

Virometix is a privately held biotechnology company developing

BiotechnologyHealth CareMedical

Series ASep 4, 2017

Amount Raised: $1,251,480

Anokion

Ecublens, Vaud, Switzerland

Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.

BiotechnologyClinical TrialsTherapeutics

Series AMay 9, 2014

Amount Raised: $37,500,000

Harry Welten

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Harry Welten frequently co-invest with?

Which angels does Harry Welten often collaborate with?

What are some of recent deals done by Harry Welten?

Ready to Raise Capital?

Pages

Free tools